TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Fri Feb 17

Hidden Gems Boards Post

TMFBiologyFool replied to the Hidden Gems boards. 3:46 PM

Wed Feb 15

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 6:15 PM

Pro Boards Post

TMFBiologyFool replied to the Pro boards. 6:04 PM

NL

Article

TMFBiologyFool published an article 4:37 PM

Why Genomic Health Inc. Jumped Higher Today

The genetic-test maker revealed a solid fourth quarter, with the promise of more growth to come.

NL

Article

TMFBiologyFool published an article 3:55 PM

Genomic Health, Inc. Swings to a Profit

The genetic-test maker gets into the black as it expands test sales outside of the U.S.

Rule Breakers article.

TMFBiologyFool published an update. 2:13 PM

Tue Feb 14

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 1:25 PM

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 1:03 PM

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 3:27 AM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 2:48 AM

Mon Feb 13

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 7:50 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 5:21 PM

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 5:05 PM

NL

Article

TMFBiologyFool published an article 3:57 PM

Seattle Genetics Earnings: Waiting on ECHELON

2017 is looking like a transition year for the biotech.

Rule Breakers article.

TMFBiologyFool published an update. 3:04 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 12:22 AM

Fri Feb 10

NL

Article

TMFBiologyFool published an article 4:29 PM

Why Ocular Therapeutix Inc Jumped Higher Today

An analyst upgrade ahead of an FDA decision for its eye-pain medication sends shares higher.

Thu Feb 9

Rule Breakers article.

TMFBiologyFool published an update. 3:49 PM

NL

Article

TMFBiologyFool published an article 3:20 PM

Alnylam Pharmaceuticals, Inc. Presents Progress -- Investors Dig It

The biotech used its fourth-quarter earnings to present plans to progress its pipeline, sending shares higher.

NL

Article

TMFBiologyFool published an article 12:54 PM

Why OraSure Technologies, Inc. Leaped Higher Today

It was an outstanding fourth quarter for the diagnostic test maker, and there's more to come this year.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 60.29
Player Rank 29635 out of 74630
Score -65.51
Score Change Today -15.59
Accuracy 67.14%
Active Picks 71
Total Picks 215
Best Pick UNH (+286.60)
Worst Pick INCY (-1171.06)
Average Score per Pick -0.30
Charms Earned 8
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Big red star, 1000 posts SN Explorer 1 Mission Team Member SN Odyssey
Board Posts 1396
Recs Received 2209
People who have rec'd these posts 632
Recs to Posts Ratio (last 30 days) 2.70
Threads Started 143
Threads Started Percentage 10.24 %
Most Frequent Board Motley Fool Supernova
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 57.81 %
Show TMFBiologyFool’s 10 Latest Posts